Trends and transitions in ledipasvir studies: A bibliometric assessment of a groundbreaking hepatitis C virus treatment

Kauthar Alshalla (), Mohammed Al-Rasheed (), Maryam Mahmoud (), Alaa Azhari () and Mahmoud Kandeel ()

International Journal of Innovative Research and Scientific Studies, 2025, vol. 8, issue 4, 1293-1305

Abstract: This study aimed to conduct a comprehensive bibliometric analysis of global research on ledipasvir from 2014 to May 2025, focusing on trends in research output, citation impact, authorship patterns, and thematic evolution. A bibliometric analysis was performed using 419 scientific articles from 199 sources indexed in Scopus. Data were extracted based on publication year, authorship, citations, keywords, and institutional affiliations. Visualization tools such as VOSviewer and Bibliometrix were employed to analyze co-authorship networks, keyword co-occurrence, and thematic trends. Inclusion criteria prioritized peer-reviewed English articles with complete bibliographic metadata. The analysis revealed a peak in publication output in 2018 (92 articles), followed by a gradual decline. The United States, Egypt, and Japan emerged as leading contributors, with Gilead Sciences and academic institutions like Cairo University playing pivotal roles. High citation rates (average of 39.57 citations per document) underscored the drug's ongoing relevance. Keyword analysis highlighted a shift from early clinical and pharmacokinetic studies to topics such as adherence, liver transplantation, and COVID-19 implications. International collaboration was robust, with 21.48% of publications involving multi-country teams. Ledipasvir research has evolved significantly, reflecting its foundational role in HCV treatment. Despite declining publication numbers, the drug's scientific impact remains strong, driven by international collaboration and diverse thematic exploration. Future research should focus on comparative efficacy, long-term outcomes, and resistance mechanisms to further inform clinical practice.

Keywords: Bibliometric; HCV; Hepatitis C Virus; Ledipasvir; Treatment. (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://ijirss.com/index.php/ijirss/article/view/8057/1794 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aac:ijirss:v:8:y:2025:i:4:p:1293-1305:id:8057

Access Statistics for this article

International Journal of Innovative Research and Scientific Studies is currently edited by Natalie Jean

More articles in International Journal of Innovative Research and Scientific Studies from Innovative Research Publishing
Bibliographic data for series maintained by Natalie Jean ().